Fund Holdings — Catalio Capital Management, LP

Total Portfolio Value:
$540.93M
Total Bought:
$171.32M
Total Sold:
$179.38M
Net Transaction:
-$8.07M
Notable People:
Catalio Capital Gp, Llc
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)53,91657,376+3,460$42.03M$43.78M8.09%+$1.75M
AbbVie Inc.(ABBV)0154,834+154,834$0$35.85M6.63%+$35.85M
BridgeBio Pharma, Inc.(BBIO)927,711622,729-304,982$40.06M$32.34M5.98%-$7.71M
Intuitive Surgical, Inc.(ISRG)56,67471,343+14,669$30.80M$31.91M5.90%+$1.11M
Ascendis Pharma A/SADR(ASND)179,926144,954-34,972$31.06M$28.82M5.33%-$2.24M
Soleno Therapeutics Inc409,944418,245+8,301$34.35M$28.27M5.23%-$6.07M
Dianthus Therapeutics, Inc.(DNTH)746,527667,615-78,912$13.91M$26.27M4.86%+$12.36M
Boston Scientific Corporation(BSX)229,046262,972+33,926$24.60M$25.67M4.75%+$1.07M
Syndax Pharmaceuticals, Inc.(SNDX)2,104,5121,614,717-489,795$19.71M$24.84M4.59%+$5.13M
Cytokinetics, Incorporated(CYTK)601,439451,581-149,858$19.87M$24.82M4.59%+$4.95M
Natera, Inc.(NTRA)97,297148,369+51,072$16.44M$23.88M4.42%+$7.45M
Regeneron Pharmaceuticals, Inc.(REGN)035,344+35,344$0$19.87M3.67%+$19.87M
Structure Therapeutics IncADS670,575651,810-18,765$13.91M$18.25M3.37%+$4.34M
uniQure N.V.SHS(QURE)417,443282,940-134,503$5.82M$16.52M3.05%+$10.70M
Disc Medicine, Inc.(IRON)30,661216,527+185,866$1.62M$14.31M2.65%+$12.68M
ABIVAX Société AnonymeADS(ABVX)0162,141+162,141$0$13.77M2.54%+$13.77M
Supernus Pharmaceuticals, Inc.(SUPN)0287,090+287,090$0$13.72M2.54%+$13.72M
Endeavour Silver Corp.(EXK)0248,987+248,987$0$13.62M2.52%+$13.62M
Phathom Pharmaceuticals, Inc.(PHAT)672,2901,128,521+456,231$6.45M$13.28M2.46%+$6.84M
Adaptive Biotechnologies Corporation(ADPT)1,396,445884,890-511,555$16.27M$13.24M2.45%-$3.03M
Avidity Biosciences Inc0263,256+263,256$0$11.47M2.12%+$11.47M
Adma Biologics Inc569,704684,508+114,804$10.37M$10.03M1.86%-$339.4K
Ultragenyx Pharmaceutical Inc.(RARE)213,402291,262+77,860$7.76M$8.76M1.62%+$1.00M
Fractyl Health, Inc.(GUTS)214,2365,214,236+5,000,000$347.1K$8.29M1.53%+$7.94M
GRAIL, Inc.(GRAL)0137,928+137,928$0$8.16M1.51%+$8.16M
Protara Therapeutics, Inc.(TARA)1,626,3701,500,793-125,577$4.93M$6.53M1.21%+$1.60M
Septerna, Inc.(SEPN)294,360294,3600$3.11M$5.54M1.02%+$2.43M
Cidara Therapeutics Inc053,333+53,333$0$5.11M0.94%+$5.11M
Kyverna Therapeutics, Inc.(KYTX)586,909586,9090$1.80M$3.52M0.65%+$1.72M
Eledon Pharmaceuticals, Inc.(ELDN)01,061,132+1,061,132$0$2.75M0.51%+$2.75M
Outset Medical, Inc.(OM)166,666118,279-48,387$3.20M$1.67M0.31%-$1.53M
Metagenomi Therapeutics, Inc.(MGX)528,993528,9930$782.9K$1.25M0.23%+$470.8K
Atai Life Sciences NvSHS196,858196,8580$431.1K$1.04M0.19%+$610.3K
Hyperfine, Inc.CL A(HYPR)760,035684,541-75,494$546.9K$992.6K0.18%+$445.7K
MoonLake ImmunotherapeuticsCL A(MLTX)162,596133,131-29,465$7.67M$954.5K0.18%-$6.72M
Karyopharm Therapeutics Inc.(KPTI)146,013142,984-3,029$629.3K$935.1K0.17%+$305.8K
Palvella Therapeutics, Inc.(PVLA)012,010+12,010$0$752.9K0.14%+$752.9K
Faeth Therapeutics, Inc.(FTH)14,71814,7180$126.3K$139.1K0.03%+$12.8K
Bicara Therapeutics Inc97,8000-97,800$908.6K$0—-$908.6K
Corcept Therapeutics Incorporated(CORT)239,1250-239,125$17.55M$0—-$17.55M
Edwards Lifesciences Corp390,9320-390,932$30.57M$0—-$30.57M
Fulcrum Therapeutics, Inc.(FULC)188,3040-188,304$1.30M$0—-$1.30M
GeneDx Holdings Corp.CL A(WGS)61,5070-61,507$5.68M$0—-$5.68M
Gilead Sciences, Inc.(GILD)226,8750-226,875$25.15M$0—-$25.15M
Halozyme Therapeutics, Inc.(HALO)191,5290-191,529$9.96M$0—-$9.96M
Mersana Therapeutics Inc1,567,4130-1,567,413$464.0K$0—-$464.0K
Replimune Group, Inc.(REPL)330,3370-330,337$3.07M$0—-$3.07M
Teva Pharmaceutical Industries LimitedADS(TEVA)1,170,3720-1,170,372$19.62M$0—-$19.62M
Vir Biotechnology, Inc.(VIR)388,3030-388,303$1.96M$0—-$1.96M
Zenas BioPharma, Inc.(ZBIO)215,3140-215,314$2.09M$0—-$2.09M
Page 1 of 1
Catalio Capital Management, LP — 13F Holdings — Q3 2025 | TickerTrail